Blackmores Cognition Ultra puts a branded citicoline on the Australian shelf, and prints the dose

Start where we always start: the panel. Blackmores lists Cognition Ultra’s active ingredients as “Citicoline (Cognizin®) 250 mg” per tablet, and the directions say to take two tablets once a day. That is one active, one number, and the arithmetic you can do in your head — 500 mg of citicoline a day, if you take it as directed. The product is sold in a single 30-tablet size, which at the labelled dose is fifteen days.

We say this rarely enough that it is worth saying plainly: this is a disclosed formula. In the panel as read here, there is no blend to unpick, no “proprietary matrix” hiding a fractional dose behind a trademark. Whatever else you conclude about the product, you can read the dose off the Blackmores product page before you buy, which is more than a lot of the cognitive-support aisle manages.

What the brand name on the ingredient actually means

Cognizin is a registered trademark of Kyowa Hakko Bio, and Blackmores says so on the page. That matters, but not in the way marketing copy implies. A branded ingredient is a supply-chain claim — a specific manufacturer, a specific process, a specific material identity — and a licensing arrangement. It is not an efficacy claim, and it does not transfer the results of any trial to the tablet in your hand. What transfers, if anything does, is the dose. A branded form studied at one intake tells you nothing about a product that delivers a third of it. Here, at least, the number is on the label where you can compare it against whatever you go and read.

Blackmores describes Cognition Ultra as a targeted cognitive support supplement and prints a single reference alongside its “benefits seen in as early as 2 weeks” line — Al-Kuraishy and Al-Gareeb, Basic and Clinical Neuroscience, 2020 — with an asterisk noting the study was conducted in healthy young adults. Read that asterisk. A result in healthy young adults is a result in healthy young adults, and the company is being straighter than most by printing the qualifier at all.

The rest is housekeeping the label already covers: it is caffeine-free, it contains sulfites, it is adults-only, Blackmores says not to use it in pregnancy or breastfeeding, and it flags a possible interaction with Parkinson’s disease medications. Always read the label and follow the directions. If you want the version of this argument where seven doses get audited one by one, we did that in Profound Focus: a debut formula that publishes all seven doses. None of this is medical advice, and a supplement being listed for sale in a market is a statement about paperwork, not about whether it will do anything for you. Talk to a health professional before adding it to anything else you take.